Your fertility specialist or reproductive endocrinologist can use a number of tests to determine whether you are fertile following cancer treatment. These include:
Follicle-stimulating hormone (FSH)
This is a simple blood test to measure hormone levels and indicate how close to menopause you are. FSH is produced in the pituitary gland. It stimulates follicles in the ovaries, which will in turn release eggs. FSH levels need to be measured on specific days of the menstrual cycle, usually within the first couple of days of a new cycle, and levels change throughout the month.
An ultrasound probe is inserted into the vagina to examine the reproductive organs including the cervix, uterus, fallopian tubes and ovaries.
Antral follicle count (AFC)
An ultrasound probe is inserted into the vagina to count the number of follicles in the ovaries; each follicle contains a single immature egg.
Anti-Müllerian hormone (AMH)
This blood test measures AMH, which is a hormone secreted by the developing egg sacs (follicles). The level of AMH in a woman’s blood is an estimate of the number of eggs left in the ovaries.
An ultrasound probe is inserted into the vagina to show the volume of the ovaries. Usually the combined volume is about 10 mL. Women with an ovarian volume of less than 4 mL often find it challenging to become pregnant.
This is produced mainly in the ovary. The level of oestrogen is a sign of a developing follicle and its egg.
Progesterone is produced in the ovary and is secreted in high amounts after ovulation. The level of progesterone in a woman is a sign of ovulation.
Luteinising hormone (LH)
A blood test can measure LH levels. This hormone helps a woman’s ovaries release an egg. High levels of LH may be a sign of premature ovarian insufficiency
This content is brought to you in partnership with Conceive Please.